Novel Ruthenium-Silver PTA-Based Polymers and Their Behavior in Water

Novel family of [RuCp(N,N)(P)]+ compounds with simultaneous anticancer and antibacterial activity: Biological evaluation and solution chemistry studies

A family of ten novel ruthenium(II)-cyclopentadienyl organometallics of general formula [Ru(η5-C5H5)(N,N)(PPh2(C6H4COOR)][CF3SO3] (1-10) in which (N,N) = 4,4'-R'-2,2'-bipyridyl (R = -H or -CH2CH2OH; R' = -H, -CH3, -OCH3, -CH2OH, and -CH2-biotin) was prepared from [Ru(η5-C5H5)(PPh2(C6H4COOH))2Cl]. All compounds were fully characterized by means of several spectroscopic and analytical techniques, and the molecular structures of [Ru(η5-C5H5)(PPh2(C6H4COOH))2Cl], 1, 3 and 4 have been additionally studied by single-crystal X-ray diffraction. The anticancer activity of all compounds was evaluated in sensitive and multidrug-resistant counterpart cell lines from human colorectal cancer (Colo 205 and Colo 320) and non-small cell lung cancer NSCLC (A549, NCI-H460 versus NCI-H460/R) as well. Notably, compounds 6 and 7 (R CH2CH2OH and (N,N) = bipy or Me2bipy, respectively) showed antiproliferative effect against both cell lines with high intrinsic selectivity towards cancer cells. The antibacterial activity of all compounds was also evaluated against both Gram negative and Gram positive strains, and some compounds in the series showed potent antibacterial activity against Staphylococcus aureus strains, including the methicillin-resistant MRSA strains. Solution speciation studies revealed that the complexes bearing the PPh2(C6H4COO-) ligand are neutral at physiological pH (7.4) in contrast with their ethylene glycol derivatives that have a permanent positive charge. While all compounds are lipophilic, the difference in the distribution coefficient for neutral and charged complexes is around one order of magnitude. Complexes 6 and 7 exhibited excellent biological activity and were selected for further studies. Spectrofluorometric methods were used to investigate their interaction with biomolecules such as human serum albumin (HSA) and calf thymus DNA (ct-DNA). For these complexes, binding site II of HSA is a possible binding pocket through non-covalent interactions. The release of ethidium from the DNA adduct by the charged complexes proves their interaction with DNA in contrast to the neutral ones. In conclusion, Ru(II)-cyclopentadienyl complexes with 2,2'-bipyridyl-derivatives and an ethylene glycol moiety tethered to the phenylphosphane co-ligand are very promising from a therapeutic perspective, in particular complexes 6 and 7 that display remarkable antibacterial activity with a high anti-proliferative effect against colon and non-small cell lung cancers, both clinically challenging neoplasias in need of effective solutions.

Insights into the κ-P,N Coordination of 1,3,5-Triaza-7-phosphaadamantane and Derivatives: κ-P,N-Heterometallic Complexes and a 15N Nuclear Magnetic Resonance Survey

Complexes {[(PTA)₂CpRu-μ-CN-1κC:2κ²N-RuCp(PTA)₂-ZnCl₃]}·2DMSO (13) {[ZnCl₂(H₂O)]-(PTA-1κP:2κ²N)(PTA)CpRu-μ-CN-1κC:2κ²N-RuCp(PTA)(PTA-1κP:2κ²N)-[ZnCl₂(H₂O)]}Cl (14), [RuCp(HdmoPTA)(PPh₃)(PTA)](CF₃SO₃)₂ (20), [RuCp(HdmoPTA)(HPTA)(PPh₃)](CF₃SO₃)₃ (21), and [RuCp(dmoPTA)(PPh₃)(PTA)](CF₃SO₃) (22) were obtained and characterized, and their crystal structure together with that of the previously published complex 18 is reported. The behavior of the 1,3,5-triaza-7-phosphatricyclo[3.3.1.13,7]decane (PTA) and 3,7-dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane (dmoPTA) ligands against protonation and κN-coordination is discussed, on the basis of ¹⁵N nuclear magnetic resonance data collected on 22 different compounds, including PTA (1), HdmoPTA (7H), and some common derivatives as free ligands (2–6 and 8), along with mono- and polymetallic complexes containing PTA and/or HdmoPTA (9–22). ¹⁵N detection via ¹H–¹⁵N heteronuclear multiple bond correlation allowed the construction of a small library of ¹⁵N chemical shifts that shed light on important features regarding κN-coordination in PTA and its derivatives.

To shed light on the behavior of the triazaphosphines 1,3,5-triaza-7-phosphatricyclo[3.3.1.13,7]decane (PTA) and 3,7-dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane (dmoPTA) upon κN coordination and N protonation, the ¹⁵N chemical shifts of 22 compounds, including PTA and a representative variety of its derivatives, piano-stool complexes, were collected by ¹H−¹⁵N heteronuclear multiple bond correlation nuclear magnetic resonance. New heterometallic complexes containing PTA were also synthesized and fully characterized.

Crystal structure and magnetic study of the complex salt [RuCp(PTA)2-μ-CN-1κC:2κN-RuCp(PTA)2][Re(NO)Br4(EtOH)0.5(MeOH)0.5]

A new RuII-ReII complex salt, μ-cyanido-κ2 C:N-bis-[(η5-cyclo-penta-dien-yl)bis(3,5,7-tri-aza-phosphaadamantane-κP)ruthenium(II)] tetra-bromido-(ethanol/methanol-κO)nitrosylrhenate(II), [Ru(CN)(C5H5)2(C6H12N3P)4][ReBr4(NO)(CH4O)0.5(C2H6O)0.5] or [RuCp(PTA)2-μ-CN-1κC:2κ2 N-RuCp(PTA)2][Re(NO)Br4(EtOH)0.5(MeOH)0.5] (PTA = 3,5,7-tri-aza-phosphaadaman-tane) was obtained and characterized by single-crystal X-ray diffraction, elemental analysis and infrared spectroscopy. The title salt was obtained by liquid-liquid diffusion of methanol/DMSO solutions of (NBu4)[Re(NO)Br4(EtOH)] and [(PTA)2CpRu-μ-CN-1κC:2κ2 N-RuCp(PTA)2](CF3SO3). The RuII and ReII independent moieties correspond to a binuclear and mononuclear complex ion, respectively. A deep geometrical parameter analysis was performed, and no significant differences were found with earlier reports containing similar mol-ecules. The magnetic properties were investigated in the temperature range 2.0-300 K, and the complex behaves as a quasi-magnetically isolated spin doublet with weak anti-ferromagnetic inter-actions.

First exfoliated Ru-Ru-Au organometallic polymer with layered structure

A new water soluble heterometallic polymeric complex [{(PTA)2CpRu-μ-CN-1κC:2κ2N-RuCp(PTA)2}-μ-{Au(CN)4}4]n·2H2O (1) is synthesized and characterized by single crystal X-ray diffraction. This complex self-assembles forming 3D polymeric structures with large scale hexagonal conformation. They also organize as 3D stacks of polymer sandwiches that can be exfoliated providing mono heterometallic-3D layers, as shown by electron microscopy. Regarding the polymer dynamics, quasi-elastic neutron scattering shows a transition from vibrational Debye-Waller behaviour to a more dynamically active state as a result of the loss of structural water molecules.

Silver(I) Complexes with Camphorsulfonato and Phosphine Ligands: Structural Diversity and Antibacterial Activity

A series of silver(I) camphorsulfonato complexes containing various phosphine ligands having the stoichiometry [Ag(camphSO₃)(PR₃)] [PR₃ = PTA (1,3,5-triaza-7-phosphaadamantane), PASO₂ (2-thia-1,3,5-triaza-7-phosphaadamantane-2,2-dioxide), PPh₃, PCy₃, P(CH₂CH₂CN)₃, PPyPh₂, or P(o-tol)₃] were prepared and fully characterized by NMR spectroscopic methods and X-ray crystallography. Depending on the nature of the phosphine, a variety of different supramolecular structures, including dimers, macrocycles, and coordination polymers, were observed in the solid state. The in vitro antimicrobial activity in seven different pathogens (Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, Candida albicans, and Cryptococcus neoformans var. grubii) as well as toxicity in human cells was also examined. While all compounds show some activity against the bacteria, they were especially active against the fungus C. neoformans. The most active and at the same time least toxic compound was found to be the water-soluble complex [Ag(camphSO₃)(PTA)₂].

Orthogonal Coordination Chemistry of PTA toward Ru(II) and Zn(II) (PTA = 1,3,5-Triaza-7-phosphaadamantane) for the Construction of 1D and 2D Metal-Mediated Porphyrin Networks

This work demonstrates that PTA (1,3,5-triaza-7-phosphaadamantane) behaves as an orthogonal ligand between Ru(II) and Zn(II), since it selectively binds through the P atom to ruthenium and through one or more of the N atoms to zinc. This property of PTA was exploited for preparing the two monomeric porphyrin adducts with axially bound PTA, [Ru(TPP)(PTA-κP)₂] (1, TPP = meso-tetraphenylporphyrin) and [Zn(TPP)(PTA-κN)] (3). Next, we prepared a number of heterobimetallic Ru/Zn porphyrin polymeric networks—and two discrete molecular systems—mediated by P,N-bridging PTA in which either both metals reside inside a porphyrin core, or one metal belongs to a porphyrin, either Ru(TPP) or Zn(TPP), and the other to a complex or salt of the complementary metal (i.e., cis,cis,trans-[RuCl₂(CO)₂(PTA-κP)₂] (5), trans-[RuCl₂(PTA-κP)₄] (7), Zn(CH₃COO)₂, and ZnCl₂). The molecular compounds 1, 3, trans-[{RuCl₂(PTA-κ²P,N)₄}{Zn(TPP)}₄] (8), and [{Ru(TPP)(PTA-κP)(PTA-κ²P,N)}{ZnCl₂(OH₂)}] (11), as well as the polymeric species [{Ru(TPP)(PTA-κ²P,N)₂}{Zn(TPP)}]_∞ (4), cis,cis,trans-[{RuCl₂(CO)₂(PTA-κ²P,N)₂}{Zn(TPP)}]_∞ (6), trans-[{RuCl₂(PTA-κ²P,N)₄}{Zn(TPP)}₂]_∞ (9), and [{Ru(TPP)(PTA-κ³P,2N)₂}{Zn₉(CH₃COO)₁₆(CH₃OH)₂(OH)₂}]_∞ (10), were structurally characterized by single crystal X-ray diffraction. Compounds 4, 6, 9, and 10 are the first examples of solid-state porphyrin networks mediated by PTA. In 4, 6, 8, 9, and 11 the bridging PTA has the κ²P,N binding mode, whereas in the 2D polymeric layers of 10 it has the triple-bridging mode κ³P,2N. The large number of compounds with the six-coordinate Zn(TPP) (the three polymeric networks of 4, 6 and 9, out of five compounds) strongly suggests that the stereoelectronic features of PTA are particularly well-suited for this relatively rare type of coordination. Interestingly, the similar 1D polymeric chains 4 and 6 have different shapes (zigzag in 4 vs “Greek frame” in 6) because the {trans-Ru(PTA-κ²P,N)₂} fragment bridges two Zn(TPP) units with anti geometry in 4 and with syn geometry in 6. Orthogonal “Greek frame” 1D chains make the polymeric network of 9. Having firmly established the binding preferences of PTA toward Ru(II) and Zn(II), we are confident that in the future a variety of Ru/Zn solid-state networks can be produced by changing the nature of the partners. In particular, there are several inert Ru(II) compounds that feature two or more P-bonded PTA ligands that might be exploited as connectors of well-defined geometry for the rational design of solid-state networks with Zn–porphyrins (or other Zn compounds).

This work demonstrates, through the X-ray structural characterization of several polymeric Ru/Zn networks, that PTA (1,3,5-triaza-7-phosphaadamantane) behaves as an orthogonal ligand between Ru(II) and Zn(II). In fact, PTA selectively binds through the P atom to ruthenium and through one or more of the N atoms to zinc.